For the quarter ending 2026-03-31, TBPH has $472,313K in assets. $288,101K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 288,101 | 167,806 | 174,773 | 281,927 |
| Short-term marketable securities | 106,565 | 147,551 | 154,907 | 56,877 |
| Receivables from collaborative arrangements | 15,584 | 45,539 | 18,267 | 21,919 |
| Receivables from milestones and royalty assets | - | 50,000 | - | - |
| Other prepaid and current assets | 7,384 | 7,564 | 6,750 | 5,571 |
| Total current assets | 417,634 | 418,460 | 354,697 | 366,294 |
| Long-term marketable securities | - | 11,128 | 3,029 | - |
| Property and equipment, net | 5,539 | 5,895 | 6,257 | 6,641 |
| Operating lease assets | 23,001 | 24,371 | 25,450 | 26,493 |
| Restricted cash | 836 | 836 | 836 | 836 |
| Other assets | 25,303 | 24,880 | 25,191 | 25,771 |
| Total assets | 472,313 | 485,570 | 415,460 | 426,035 |
| Accounts payable | 1,100 | 2,568 | 2,213 | 1,675 |
| Accrued personnel-related expenses | 8,730 | 12,592 | 10,330 | 7,259 |
| Accrued clinical and development expenses | 2,396 | 3,373 | 5,842 | 3,783 |
| Accrued general and administrative expenses | 2,522 | 2,052 | 2,699 | 2,459 |
| Operating lease liabilities | 10,752 | 10,945 | 10,914 | 10,896 |
| Income tax payable | 5,287 | 5,287 | 4,074 | 26,696 |
| Other accrued liabilities | 988 | 1,485 | 1,335 | 1,865 |
| Total current liabilities | 31,775 | 38,302 | 37,407 | 54,633 |
| Long-term operating lease liabilities | 29,752 | 31,758 | 33,681 | 35,561 |
| Unrecognized tax benefits | - | - | 79,165 | 77,805 |
| Future royalty payment contingency | 32,795 | 32,795 | 32,213 | 31,640 |
| Unrecognized tax benefits | 87,153 | 85,679 | - | - |
| Other long-term liabilities | 244 | 313 | 313 | 1,548 |
| Ordinary shares, 0.00001 par value per share 200,000 shares authorized 51,515 and 51,069 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 1 | 1 | 1 | 1 |
| Additional paid-in capital | 1,155,215 | 1,156,288 | 1,153,299 | 1,149,123 |
| Accumulated other comprehensive income | -62 | 61 | 32 | -10 |
| Accumulated deficit | -864,560 | -859,627 | -920,651 | -924,266 |
| Total shareholders' equity | 290,594 | 296,723 | 232,681 | 224,848 |
| Total liabilities and shareholders' equity | 472,313 | 485,570 | 415,460 | 426,035 |
Theravance Biopharma, Inc. (TBPH)
Theravance Biopharma, Inc. (TBPH)